Minerva Neurosciences (NERV) Revenue & Revenue Breakdown
Minerva Neurosciences Revenue Highlights
0
Latest Revenue (Q)
$42.22K
Minerva Neurosciences Revenue by Period
Minerva Neurosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2020-12-31 | $41.18M | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | - |
Minerva Neurosciences generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Minerva Neurosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $42.22K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $0.04 | 100.00% |
| 2020-09-30 | - | -100.00% |
| 2020-06-30 | $41.18M | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | - |
Minerva Neurosciences generated $42.22K in revenue during Q4 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Minerva Neurosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| DAWN | Day One Biopharmaceuticals | $131.16M | $29.21M |
| WVE | Wave Life Sciences | $108.30M | $83.75M |
| EYPT | EyePoint Pharmaceuticals | $43.27M | $11.59M |
| XFOR | X4 Pharmaceuticals | $2.56M | $28.81M |
| EYEN | Eyenovia | $57.34K | $28.09K |
| KOD | Kodiak Sciences | - | - |
| ALXO | ALX Oncology | - | - |
| CABA | Cabaletta Bio | - | - |
| ZURA | Zura Bio | - | $2.00K |
| CGTX | Cognition Therapeutics | - | - |
| ANNX | Annexon | - | - |
| RNAZ | TransCode Therapeutics | - | - |
| ABOS | Acumen Pharmaceuticals | - | - |
| INZY | Inozyme Pharma | - | - |
| LPTX | Leap Therapeutics | - | - |
| INAB | IN8bio | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| VIRX | Viracta Therapeutics | - | - |
| NERV | Minerva Neurosciences | - | $42.22K |
| BMEA | Biomea Fusion | - | - |
| MREO | Mereo BioPharma Group | - | - |